Short communicationEffectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis
Introduction
Use of venous access ports has increased over the last decade and nowadays they are commonly used in the management of oncology patients. Port-related infections increase hospital-related costs and are a well-recognised source of patient morbidity and mortality. Coagulase-negative staphylococci (CoNS) are the most common pathogen involved. Removal of a surgically implantable vascular device is often a management challenge and it is important to determine the role of conservative therapeutic approaches. Antibiotic lock therapy (ALT) is recommended in guidelines as treatment for patients with CoNS catheter-related bacteraemia [1], [2], [3]. Success rates have varied substantially among studies and, even in non-complicated patients, a 100% rate has not been reached [4]. Vancomycin is considered the agent of choice to perform antimicrobial locks when staphylococci are involved. Teicoplanin is a glycopeptide with an antimicrobial spectrum similar to that of vancomycin that has shown better binding to siliconised polymers [5]. This phenomenon might be relevant in the effectiveness of antimicrobial locks to treat port-related bloodstream infections (BSIs) since silicone is the main inner surface port component. However, there is a lack of clinical research into this topic. The aim of this study was to compare the effectiveness of teicoplanin lock therapy versus vancomycin lock therapy in the treatment of CoNS venous access port-related BSI.
Section snippets
Study location
The study was carried out in a 350-bed university hospital in which approximately 300 venous access ports are implanted every year. All participants provided informed consent.
Study design and patients
An observational study was prospectively conducted including consecutive patients with port-related bacteraemia diagnosed at Clínica Universidad de Navarra (Pamplona, Spain). All hospitalised and non-hospitalised patients with a venous access port in place were eligible for inclusion. During the 36-month study period (1
Results
In total, 90 patients were diagnosed with port-related bacteraemia. However, 28 patients with port-related BSIs other than CoNS and 5 patients with polymicrobial BSIs were excluded. In addition, 13 patients were also excluded because of the presence of pocket or subcutaneous tract infection (10), unstable clinical status (2) or existence of a metastatic complication (1). Thus, 44 patients were diagnosed with CoNS port-related BSI and included in the study. Table 1 illustrates that both
Discussion
To the best of our knowledge, this is the first study to compare vancomycin and teicoplanin as lock solutions for the treatment of CoNS port-related BSI. Moreover, this is the largest prospective study on the outcome of port-related CoNS BSI treated with ALT. The present study shows that in patients with a CoNS port-related BSI, the use of vancomycin or teicoplanin locks has an effectiveness of nearly 90%. Moreover, this study shows that teicoplanin locks reduce the failure rate to cure the
References (16)
- et al.
Efficacy of a central venous catheter (Hydrocath) loaded with teicoplanin in preventing subcutaneous staphylococcal infection in the mouse
Zentralbl Bakteriol
(1993) - et al.
Guidelines for the management of intravascular catheter-related infections
Clin Infect Dis
(2001) - et al.
Catheter-related infections: diagnosis and intravascular treatment
J Chemother
(2001) - et al.
Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy
J Antimicrob Chemother
(2006) - et al.
Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study
J Antimicrob Chemother
(2006) - et al.
Binding of teicoplanin and vancomycin to polymer surfaces
J Antimicrob Chemother
(1994) - et al.
Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis
Eur J Clin Microbiol Infect Dis
(1992) - et al.
Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection
Ann Intern Med
(2005)
Cited by (28)
Use of 2% taurolidine lock solution for treatment and prevention of catheter-related bloodstream infections in neonates: a feasibility study
2024, Journal of Hospital InfectionESCMID* guideline for the diagnosis and treatment of biofilm infections 2014
2015, Clinical Microbiology and InfectionInefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro
2015, International Journal of Antimicrobial AgentsManagement of infections related to totally implantable venous-access ports: Challenges and perspectives
2014, The Lancet Infectious DiseasesCitation Excerpt :Glycopeptides given for 10–14 days have been used extensively. A prospective uncontrolled study identified a trend towards better outcomes with teicoplanin than with vancomycin.90,98 Daptomycin might be suitable as an alternative.115,116
Outcome of central venous catheter-related bacteraemia according to compliance with guidelines: Experience with 91 episodes
2012, Journal of Hospital InfectionCitation Excerpt :Finally, the overall medical management followed the guidelines in only 38 of the 91 episodes (41.8%). This poor adherence to the guidelines might explain the poor clinical outcome in this series: although the overall cure rate was 72.5%, in compliance with recently published clinical studies, cure with catheter salvage was observed in only a few episodes (35.3%).7,16–18 This real-life cure rate with catheter salvage is lower than what has most frequently been reported, but is in accordance with another recent study, which found 30% catheter salvage.7,18,19,25,32